EPSRC Reference: |
EP/H046526/1 |
Title: |
Multimodality Techniques for Cancer Diagnosis and Therapy |
Principal Investigator: |
ter Haar, Professor GRt |
Other Investigators: |
|
Researcher Co-Investigators: |
|
Project Partners: |
|
Department: |
Division of Radiotherapy and Imaging |
Organisation: |
Institute of Cancer Research |
Scheme: |
Platform Grants |
Starts: |
01 October 2010 |
Ends: |
30 September 2015 |
Value (£): |
1,400,150
|
EPSRC Research Topic Classifications: |
Med.Instrument.Device& Equip. |
|
|
EPSRC Industrial Sector Classifications: |
No relevance to Underpinning Sectors |
|
|
Related Grants: |
|
Panel History: |
Panel Date | Panel Name | Outcome |
24 Mar 2010
|
Platform Panel Meeting
|
Announced
|
|
Summary on Grant Application Form |
Many of the key opportunities that currently exist for improving the diagnosis and treatment of cancer are cross-disciplinary. Imaging now crucially underpins all therapeutic procedures. The Joint Department of Physics has developed and implemented methods for accurately delivering different radiation therapies to tumours using CT, Magnetic Resonance (MR) and/or ultrasound (US) imaging, but the use of emerging molecular imaging techniques (such as Positron Emission Tomography (PET), functional MR, US and optoacoustic imaging) will give us the opportunity to define targets according to biochemical or metabolic function. A major challenge in therapeutics is organ motion: here, for example, we are developing methods for pre-treatment modelling using MR, real-time US and intelligent x-ray tracking to guide radio- and US therapy. There are significant challenges in developing cross-disciplinary projects. These include training and retention of staff with the key combination of skills in imaging physics, therapy and clinical application, and the development of specialist multi-modality equipment, molecular imaging probes and histological techniques to support pilot studies. For example, satisfying the needs of both x-ray imaging and MR compatibility, can be challenging. A particular challenge in this sector is the translation of laboratory research to a stage where it may be tested in clinical trials. We are uniquely placed for addressing these. Platform funding will help us to retain researchers with the highly specialist key skills, to fund the pilot work for multi-modality applications and to allow translation of research results to a stage where they are ready for exploitation either in our clinics or by collaboration with industry.
|
Key Findings |
This information can now be found on Gateway to Research (GtR) http://gtr.rcuk.ac.uk
|
Potential use in non-academic contexts |
This information can now be found on Gateway to Research (GtR) http://gtr.rcuk.ac.uk
|
Impacts |
Description |
This information can now be found on Gateway to Research (GtR) http://gtr.rcuk.ac.uk |
Summary |
|
Date Materialised |
|
|
Sectors submitted by the Researcher |
This information can now be found on Gateway to Research (GtR) http://gtr.rcuk.ac.uk
|
Project URL: |
|
Further Information: |
|
Organisation Website: |
http://www.icr.ac.uk |